| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8368244 | Advances in Medical Sciences | 2018 | 5 Pages |
Abstract
The enzymatic resistance against aminoglycosides in northeastern Poland among clinical isolates of E. coli is predominantly caused by aac(6â²)-Ib and aph(3”)-Ib. Amikacin may be used for therapy of infections caused by ESBL-producing E. coli, because of the low rates of resistance.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Dominika Ojdana, Anna SieÅko, PaweÅ Sacha, Piotr Majewski, Piotr Wieczorek, Anna Wieczorek, Elżbieta Tryniszewska,